Maziar Doustdar, EVP of International Operations at Novo Nordisk
Professional Overview
Maziar Doustdar is an accomplished senior executive with extensive experience in the pharmaceutical industry. As the Executive Vice President (EVP) of International Operations at Novo Nordisk, he oversees the company's global operations outside of North America, leading a team of over 20,000 employees across 70 countries. Doustdar's expertise spans strategic planning, business development, and operational excellence, with a proven track record of driving growth and profitability in emerging markets.
Experience Summary
Current Role
As EVP of International Operations at Novo Nordisk, Doustdar is responsible for the company's commercial activities, supply chain, and regulatory affairs in markets outside of North America. Under his leadership, Novo Nordisk's international revenue has grown by over 25% in the past 5 years, with a strong focus on expanding access to essential diabetes and obesity treatments in underserved regions. Doustdar also serves as a member of the Board of Directors at Orion Corporation, a leading Finnish pharmaceutical company, where he provides strategic guidance and oversight.
Career Progression
Doustdar joined Novo Nordisk in 1992 and has steadily progressed through the organization, taking on roles of increasing responsibility in finance, IT, and general management. Prior to his current position, he served as EVP of Emerging Markets, SVP of Emerging Markets, and Regional Corporate Vice President, overseeing the company's expansion into high-growth markets in Asia, Africa, and Latin America. Doustdar's deep understanding of local market dynamics and ability to navigate complex regulatory environments have been instrumental in driving Novo Nordisk's global success.
Academic Background
Doustdar holds a Master's degree in Business Administration from the University of Zurich, where he specialized in Finance and International Business. He has also completed executive leadership programs at prestigious institutions, such as the Harvard Business School and INSEAD, further enhancing his strategic and managerial capabilities.
Areas of Expertise
- Pharmaceutical industry operations and supply chain management
- Emerging markets strategy and business development
- Regulatory affairs and market access
- Financial management and business performance optimization
- Cross-cultural leadership and team building
Professional Impact
Under Doustdar's leadership, Novo Nordisk has significantly expanded its global footprint, particularly in high-growth markets. He has spearheaded the company's efforts to improve access to essential diabetes and obesity treatments, collaborating with governments, healthcare organizations, and patient advocacy groups to address critical unmet needs. Doustdar's strategic vision and operational expertise have been instrumental in Novo Nordisk's continued growth and position as a global leader in the pharmaceutical industry.
Conclusion
Maziar Doustdar's extensive experience, strategic vision, and operational acumen have made him a respected leader in the pharmaceutical industry. As EVP of International Operations at Novo Nordisk, he continues to drive the company's global expansion and impact, leveraging his deep understanding of local markets and commitment to improving patient outcomes worldwide.
